Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-011992
Filing Date
2021-05-13
Accepted
2021-05-13 14:01:49
Documents
51
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20210331_10q.htm 10-Q 910519
2 EXHIBIT 31.1 CERTIFICATION OF CO-CEOS ex_247040.htm EX-31.1 13547
3 EXHIBIT 31.2 CERTIFICATION OF CFO ex_247041.htm EX-31.2 15586
4 EXHIBIT 32.1 CERTIFICATION OF CO-CEOS PURSUANT TO 18 USC ex_247042.htm EX-32.1 9502
5 EXHIBIT 32.2 CERTIFICATION OF CFO PURSUANT TO 18 USC ex_247043.htm EX-32.2 7354
  Complete submission text file 0001437749-21-011992.txt   4515719

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20210331.xml EX-101.INS 1003471
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20210331.xsd EX-101.SCH 41443
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20210331_cal.xml EX-101.CAL 41372
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20210331_def.xml EX-101.DEF 284462
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20210331_lab.xml EX-101.LAB 246078
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20210331_pre.xml EX-101.PRE 301417
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 21918591
SIC: 2834 Pharmaceutical Preparations